| ABBOTT LABORATORIES |
| USA |
| Gesundheit |
| US0028241000 / 850103 |
| ABL (Frankfurt) / ABT (NYSE) |
| FRA:ABL, ETR:ABL, ABL:GR, NYSE:ABT |
| S&P500 |
| https://www.abbott.com/ |
|
Abbott Laboratories, a globally renowned company, ..
>Volltext.. |
| 186307.18 Mio. EUR |
| 191012.72 Mio. EUR |
| 37346.57 Mio. EUR |
| 9409.26 Mio. EUR |
| 11836.11 Mio. EUR |
| 6.82 EUR |
| 11023.47 Mio. EUR |
| 6398.06 Mio. EUR |
| 7767.79 Mio. EUR |
| 0.53 |
| 0.93% |
| 129.49% |
| 2.02 EUR |
| 1.88% |
| 2% |
| 15.10.25 - 0.50622€ 15.07.25 - 0.50622€ >weitere anzeigen... |
| - |
| ABBOTT LABORATORIES, ABBOTT LABS, ABBOTT LAB |
| 31.12.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|